FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...

Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

18, 2025 – The FDA has approved a new 5-in-1 shot to protect ... Penmenvy combines parts of the well-established Bexsero and Menveo vaccines into a single shot, protecting against the five ...

The FDA has approved an Investigational New Drug application for Fapon Biopharma’s FP008, an immunocytokine designed for patients with solid tumors that have not responded to existing PD-1-targeting ...

It's an important meeting. What's the plan for flu vaccines this year," Dr. Paul Offit, a member of the FDA advisory committee and director of the Vaccine Education Center at Children's Hospital ...

The case, called Missouri et al. v. FDA, is a revamped version of a lawsuit filed by anti-abortion groups and doctors in 2023 seeking to block the Food and Drug Administration’s (FDA) approval ...

The vaccine is an injectable suspension for intramuscular use that combines components of GlaxoSmithKline's 2 well-established meningococcal vaccines, Bexsero and Menveo. HealthDay News — The U.S.

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's ...

MANILA – The Philippine Economic Zone Authority (Peza) has approved P52.93 billion worth of investment pledges in the first two months of the year. PEZA reported Tuesday that its investment ...